Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Delaware Post.
Press releases published on August 11, 2025
Diamond State of Mind (DSM) Announces Part III of Its 'In Chains' Series at the White House
EIN Presswire
·
August 11, 2025
Diamond State of Mind, a for-profit social justice and cultural equality advocacy platform, is set to host its "In Chains" series at the White House this week. WILMINGTON, DE, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Diamond State of Mind ( …
My Home Pathway and Liberty Bank Announce Strategic Partnership to Expand Homeownership Opportunities
EIN Presswire
·
August 11, 2025
Community Development Financial Institution (CDFI) leverages innovative fintech partner to help consumers and increase revenue. NEW ORLEANS, LA, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- My Home Pathway, a pioneering financial technology …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
GlobeNewswire
·
August 11, 2025
WILMINGTON, Del., Aug. 11, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its second quarter 2025 financial results …
AI/R Company transforma mudança para o CNPJ alfanumérico em uma evolução tecnológica para seus clientes
GlobeNewswire
·
August 11, 2025
SÃO PAULO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- A Receita Federal do Brasil anunciou que, a partir de julho de 2026, o Cadastro Nacional da Pessoa Jurídica (CNPJ) adotará um novo padrão alfanumérico, mantendo os 14 caracteres, mas agora combinando letras e …
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
GlobeNewswire
·
August 11, 2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …